期刊文献+

促进骨形成的甲状旁腺激素:作用及机制 被引量:7

The role and mechanism of parathyroid hormone in promoting bone formation
下载PDF
导出
摘要 背景:骨质疏松是表现为骨矿化密度低下以及骨微结构不良,从而易导致骨折发生的一种疾病,常并发口腔表征。甲状旁腺激素是在骨形成以及钙盐沉积过程中的重要调节因素,间歇性的甲状旁腺激素注射已经被广泛的证实可以促进骨质的形成。目的:探讨甲状旁腺激素增强骨密度以及调节骨形成代谢的可能细胞及分子机制。方法:由第一作者用计算机检索全国期刊全文数据库(CNKI),Medline数据库,检索词分别为"甲状旁腺激素,骨质疏松,成骨细胞,骨形成"和"Parathyroid hormone;osteoporosis;osteoblast;osteogenesis"。从甲状旁腺激素对成骨细胞分化、增殖的作用,甲状旁腺激素对成骨细胞凋亡的作用,甲状旁腺激素与Wnt/β-catenin通路以及其他细胞因子的作用关系3个方面进行总结。按纳入和排除标准对文献进行筛选,共纳入41篇文章。结果与结论:甲状旁腺激素作用于甲状旁腺激素Ⅰ型受体,触发经典的G蛋白信号通路。甲状旁腺激素主要通过蛋白激酶信号A通路,调节其下游反应蛋白。间歇性使用甲状旁腺激素提高成骨细胞增殖能力,提高成骨细胞骨转录因子runx2和骨钙素(m RNA和蛋白水平)的表达,通过对抗氧化应激抑制成骨细胞凋亡,从而促进成骨。 BACKGROUND: Osteoporosis is characterized by low bone mineral density and/or poor bone microarchitecture leading to an increased risk of fractures. Oral manifestations can be frequently discovered in osteoporosis patients. Osteoporosis therapies have mostly relied on antiresorptive drugs. Parathyroid hormone plays a significant role in osteogenesis and calcium deposition. Intermittent exposure to parathyroid hormone has been widely proved to lead to a net increase in bone formation. OBJECTIVE: To discuss the possibly cellular and molecular mechanism of parathyroid hormone in strengthening the bone mineral density and regulating bone formation. METHODS: An online search of CNKI and Medline databases was performed for relevant articles using keywords of "parathyroid hormone; osteoporosis; osteoblast; osteogenesis" in Chinese and English, respectively. Relevant articles were summarized from three aspects: effects of parathyroid hormone on differentiation and proliferation of osteoblasts, effects of parathyroid hormone on osteoblast apoptosis, and the relationship of parathyroid hormone with Wnt/beta-catenin pathway and other cytokines. According to inclusioncriteria, 41 articles were retained at last. RESULTS AND CONCLUSION:Parathyroid hormone exerts an effect on parathyroid hormone type Ⅰ receptor, triggering a classic G protein signaling pathway. Parathyroid hormone mainly works through protein kinase A signaling pathway, adjusting its downstream c-reactive protein. Intermittent use of parathyroid hormone can increase osteoblast proliferation, increase osteoblast runx2 and osteocalcin at m RNA and protein levels, inhibit osteoblast apoptosis by against oxidative stress, so as to promote osteogenesis.
出处 《中国组织工程研究》 CAS 北大核心 2015年第15期2405-2409,共5页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金面上项目(81271122)资助~~
  • 相关文献

参考文献41

  • 1Harvey N,Dennison E, Cooper C.Osteoporosis: impact on health and economics. Nat Rev Rheumatol.2010;6(2):99-105.
  • 2Anil S. Preethanath RS, AIMohadb HS, et al.lmpact of osteoporosis and its treatment on oral health. Am J Med Sci. 2013;346(5):396-401.
  • 3Dervis E.Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2005;100(3):349-56.
  • 4Cheung A, Seeman E.Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med.2010;363(25):2473-2474.
  • 5Tang ZL, Zhang W J, Wang DX, et aI.An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. J Oral Maxillofac Surg.2014;72(2):419-430.
  • 6Tokunaga K, Seto H, Ohba H, et al. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis. J Periodontal Res. 2011; 46(6):655-662.
  • 7Cranney, A, Papaioannou A, Zytaruk N, et al. Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ, 2006;175(1):52-59.
  • 8Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med.2001; 344(19):1434-1441.
  • 9Jilka RL.Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone. 2007;40(6): 1434-1446.
  • 10Silva BC, Costa AG, Cusano NE et al. Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest. 2011 ;34(10):801-810.

二级参考文献23

  • 1金慰芳,丰盛梅,顾淑珠,高建军,周轶,王洪复.外源性PTH对摘卵大鼠骨髓PPARγ mRNA表达的影响[J].中国骨质疏松杂志,2006,12(6):547-549. 被引量:3
  • 2Feng Jiao, Liu Yan-hua, Xiao Yun, et al. A novel human parathyroid hormone ( 1-34 ) analog for the treatment of osteoporosis. Peptides ,2009,30 (6) : 1173.
  • 3Whitfield J, Fmorley P, Willick GE, et al. Comparison of the ability of recombinant human parathyroid hormone rhPTH ( 1-84 ) and rhPTH(1-34) to stimulate femoral trabecular bone growth in ovariectom izedrats. Calcified tissueint, 1997,60 : 26-29.
  • 4Oconnor MB, Umulis D, Othmer HG, et al. Shaping BMP morphogen gradient in the drosophila embroy and pupalwing development, 2006,133 (2) : 183-193.
  • 5Hai jman A, Dsouza RN, Bronckers AL, et aI. BMP-7 ( BMP-7 ) affects mRNA expression of type Ⅰ, Ⅱ , Ⅹ collagen, and matrixgla protein in ossifying long bones in vitro. J Bone Miner Res, 1997, 12 (11) :18215-18231.
  • 6Morgan EF, Mason ZD, Bishop G, et al. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing. Cell Physiol, 2008,43 (6) : 1031-1038.
  • 7Varady P, Li JZ, Cunningham M, et al. Morphologicanalysis of BMP-9 gene therapy induced osteogenesis. Hum Gene Ther,2001, 12(9) :697-710.
  • 8Helm GA,Alden TD, Beres E J, et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodes is in the rrodent. J Neuro Surg,2000,92 ( suppl ) :191-196.
  • 9Vonbubnof A,Cho KW. Intracellular bmps ignalingegul at ioninve tebrates : pathway or net work. Devboil ,2001,269 ( 7 ) : 1-14.
  • 10Scheideler M, Elabd C, Zaragosi LE, et al. Comparative transcriptomics of human muhipotent stem cells during adi- pogenesis and osteoblastogenesis [ J ]. BMC genomics, 2008, 9: 340.

共引文献8

同被引文献58

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部